Colombia, a pioneer in medical cannabis legalization in Latin America, is on the cusp of a major shift in its cannabis policy. A new draft decree proposes allowing the sale of dry cannabis flower, a long-awaited change for patients who have been restricted to compounded formulations and other products. This move, however, faces regulatory hurdles and scientific concerns, potentially delaying access to dry flower for patients by at least a year and a half.